2023-11-16 09:18 | CC:CRDL | Cardiol Therapeutics Inc | 1.14 | News Release200 | Cardiol presents CardiolRx study results at MPD2023 |
2023-11-14 16:45 | CC:CRDL | Cardiol Therapeutics Inc | 1.19 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-14 16:41 | CC:CRDL | Cardiol Therapeutics Inc | 1.19 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-01 10:27 | CC:CRDL | Cardiol Therapeutics Inc | 1.17 | News Release200 | Cardiol enrolls over 50% of patients in CardiolRx study |
2023-10-20 17:16 | CC:CRDL | Cardiol Therapeutics Inc | 0.94 | News Release200 | Cardiol's share price sinks below Nasdaq $1 (U.S.) min. |
2023-10-10 10:00 | CC:CRDL | Cardiol Therapeutics Inc | 1.18 | News Release200 | Cardiol's CRD-38 study shows cardioprotective effects |
2023-09-19 10:39 | CC:CRDL | Cardiol Therapeutics Inc | 1.31 | News Release200 | Cardiol expects full enrolment in Archer phase 2 trial |
2023-08-10 17:07 | CC:CRDL | Cardiol Therapeutics Inc | 1.31 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-08-08 12:53 | CC:CRDL | Cardiol Therapeutics Inc | 1.60 | News Release200 | Cardiol Therapeutics meets Nasdaq minimum bid price |
2023-06-29 16:13 | CC:CRDL | Cardiol Therapeutics Inc | 1.06 | News Release200 | Cardiol shareholders elect eight directors at AGM |
2023-06-27 12:38 | CC:CRDL | Cardiol Therapeutics Inc | 1.05 | News Release200 | Cardiol Therapeutics to hold virtual AGM June 28 |
2023-05-15 16:20 | CC:CRDL | Cardiol Therapeutics Inc | 0.74 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-15 16:20 | CC:CRDL | Cardiol Therapeutics Inc | 0.74 | SEDAR MD & A815 | SEDAR MD & A |
2023-03-29 10:06 | CC:CRDL | Cardiol Therapeutics Inc | 0.65 | News Release200 | Cardiol Therapeutics' Dec. 31 cash at $59.5-million |
2023-03-28 18:33 | CC:CRDL | Cardiol Therapeutics Inc | 0.65 | SEDAR Annual Report803 | SEDAR Annual Report |
2023-03-28 18:31 | CC:CRDL | Cardiol Therapeutics Inc | 0.65 | SEDAR MD & A815 | SEDAR MD & A |
2023-03-28 18:30 | CC:CRDL | Cardiol Therapeutics Inc | 0.65 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2023-03-07 10:13 | CC:CRDL | Cardiol Therapeutics Inc | 0.71 | News Release200 | Cardiol says cannabidiol reduces cardiac dysfunction |
2023-01-17 11:13 | CC:CRDL | Cardiol Therapeutics Inc | 1.01 | News Release200 | Cardiol's phase 2 Cardiolrx study enrolls first patient |
2022-12-12 09:37 | CC:CRDL | Cardiol Therapeutics Inc | 1.05 | News Release200 | Cardiol Therapeutics begins phase II CardiolRx study |
2022-12-02 08:24 | CC:CRDL | Cardiol Therapeutics Inc | 0.66 | In the News525 | Globe says Velan, others fit Ben Graham screen well |